Peptides & GLP-1sWeak evidence

BPC-157: what the research actually supports

One of the most-searched research peptides, and one of the least studied in actual humans.

Written and fact-checked by the Good Supplements research team8 min readUpdated September 17, 2026
BPC-157: what the research actually supports
Worth considering if
  • Researchers running their own literature-informed experiments, aware of the legal and evidentiary gaps
  • People who've already read the animal data and understand it doesn't guarantee a human effect
Skip it if
  • You're expecting the tendon-healing effects seen in rat studies to transfer directly to you
  • You want a compound with an established human dosing protocol
  • You live somewhere peptide possession or import carries legal risk
Typical trial dose: No established human dose exists; forum protocols commonly cite 250-500mcg/day, unvalidated in trials

What it is

BPC-157 is a synthetic fragment derived from a protein naturally found in human gastric juice. The theory behind it, that a stomach-protective peptide might also accelerate healing elsewhere in the body, comes almost entirely from laboratory work in rodents over the past two decades.

It's sold online as a 'research chemical' rather than a supplement or drug, which matters: it isn't reviewed for purity, dose accuracy, or safety by any regulator, and the label on a vial tells you what the seller says is inside, not what an independent lab confirmed.

What the evidence actually shows

The rat and mouse data is genuinely extensive. Studies report BPC-157 speeding healing in Achilles tendon injuries, ligament damage, and several models of gut inflammation in rodents. That volume of animal data is real, and it's why the peptide has such a strong reputation online.

What's missing is the next step. As of 2026, there is no published randomized controlled trial testing BPC-157 in humans for tendon repair, injury recovery, or any other claimed use. A rat's Achilles tendon isn't a human's. Most compounds that succeed in rodent injury models never replicate in human trials, largely because rodent healing biology and injected-vs-oral bioavailability differ substantially from ours.

The FDA has also flagged BPC-157 specifically, removing it from the list of substances compounding pharmacies can legally prepare, citing insufficient safety data. That's a regulatory signal worth weighing alongside the popularity.

Dosing and administration

No human trial has established a dose. Every protocol you'll find online, injection site, frequency, cycle length, comes from anecdote and extrapolated animal dosing rather than controlled human data. Compare that to something like creatine or vitamin D3, where hundreds of human trials converge on a range, and the gap in reliability is stark.

Most sold vials require reconstitution with bacteriostat water and subcutaneous injection, which introduces its own risks around sterility and technique if you're not working with a clinician.

Risks and unknowns

Long-term human safety data doesn't exist because long-term human trials don't exist. Reported side effects online, injection-site irritation, nausea, are self-reported and unverified. There's no dataset on interactions with medications, effects during pregnancy, or outcomes beyond a few months of use.

If you're set on trying it, the safer starting point is treating it as an unregulated compound with promising but incomplete evidence, sourcing from a vendor that publishes third-party purity testing, and talking to a doctor about your specific situation rather than a forum thread.

Weak evidence

Mostly animal or preliminary data. Human trials are sparse or use unreliable doses. See the full grading scale.

Common questions

No published randomized controlled trial has tested BPC-157 in humans as of 2026. Every claimed benefit traces back to animal studies, mostly in rats and mice.

Sources referenced

  • Seiwerth et al., systematic review of BPC-157 preclinical data
    Summarizes rodent-model outcomes across tendon, ligament and GI healing; notes absence of human RCTs.
  • FDA compounding risk list update
    BPC-157 added to substances excluded from compounding due to insufficient safety and efficacy data in humans.
  • Vendor product pages reviewed for this guide
    BioLongevity Labs and Limitless Biotech BPC-157 listings, cross-checked for dosing claims against published literature.
This guide is educational and reflects published research as of the update date above. It isn't a substitute for individualized medical advice. Talk to a doctor or pharmacist before starting any supplement if you're pregnant, nursing, managing a chronic condition, or taking prescription medication.

BPC-157 questions

This guide is written to answer these searches: bpc-157, bpc-157 dosage, bpc-157 benefits, bpc-157 side effects, is bpc-157 legal, bpc-157 human studies.